AbbVie
ABBV
#29
Rank
HK$3.833 T
Marketcap
HK$2,170
Share price
1.49%
Change (1 day)
20.85%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : HK$1.106 Trillion

According to AbbVie's latest financial reports the company's total liabilities are HK$1.106 Trillion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31HK$1.067 T4.32%
2024-12-31HK$1.023 T5.39%
2023-12-31HK$970.89 B2.26%
2022-12-31HK$949.45 B-7.12%
2021-12-31HK$1.022 T-4.08%
2020-12-31HK$1.065 T40.65%
2019-12-31HK$757.68 B42.71%
2018-12-31HK$530.91 B3.45%
2017-12-31HK$513.22 B7.68%
2016-12-31HK$476.61 B25.23%
2015-12-31HK$380.59 B90.4%
2014-12-31HK$199.89 B4.34%
2013-12-31HK$191.57 B4.53%
2012-12-31HK$183.27 B210.94%
2011-12-31HK$58.94 B39.44%
2010-12-31HK$42.27 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
HK$907.44 B-17.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$850.66 B-23.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$658.78 B-40.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$103.88 B-90.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$295.19 B-73.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$512.53 B-53.68%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$513.70 B-53.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$463.34 B-58.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
HK$13.06 B-98.82%๐Ÿ‡บ๐Ÿ‡ธ USA